Schonfeld Strategic Advisors LLC Cuts Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Schonfeld Strategic Advisors LLC lowered its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 42.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 28,200 shares of the medical device company's stock after selling 20,558 shares during the quarter. Schonfeld Strategic Advisors LLC's holdings in Cooper Companies were worth $2,592,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Fulton Bank N.A. grew its position in Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock worth $342,000 after buying an additional 109 shares during the period. Covestor Ltd raised its holdings in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares during the last quarter. Torray Investment Partners LLC boosted its position in Cooper Companies by 0.8% during the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock worth $1,488,000 after purchasing an additional 132 shares in the last quarter. Mather Group LLC. grew its holdings in Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock valued at $177,000 after purchasing an additional 133 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its position in shares of Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock valued at $93,000 after buying an additional 136 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Analysts Set New Price Targets

Several research firms recently commented on COO. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. JPMorgan Chase & Co. dropped their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Friday, March 7th. Robert W. Baird reduced their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Stifel Nicolaus lowered their target price on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Finally, Citigroup cut their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Cooper Companies currently has an average rating of "Moderate Buy" and a consensus target price of $110.25.

Cooper Companies Trading Down 0.8 %

Cooper Companies stock traded down $0.65 during trading on Friday, hitting $82.27. The company's stock had a trading volume of 1,265,544 shares, compared to its average volume of 1,447,855. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The stock's fifty day moving average is $80.54 and its 200 day moving average is $90.93. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market capitalization of $16.45 billion, a price-to-earnings ratio of 42.19, a P/E/G ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.